BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11564462)

  • 21. Interactions between oxiracetam, aniracetam and scopolamine on behavior and brain acetylcholine.
    Spignoli G; Pepeu G
    Pharmacol Biochem Behav; 1987 Jul; 27(3):491-5. PubMed ID: 3659072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ganglioside GM1 attenuates scopolamine-induced amnesia in rats and mice.
    Silva RH; Felicio LF; Frussa-Filho R
    Psychopharmacology (Berl); 1999 Jan; 141(2):111-7. PubMed ID: 9952034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynorphin A-(1-13) potently improves scopolamine-induced impairment of passive avoidance response in mice.
    Ukai M; Kobayashi T; Shinkai N; Shan-Wu X; Kameyama T
    Eur J Pharmacol; 1995 Feb; 274(1-3):89-93. PubMed ID: 7768285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Memory modulation with peripherally acting cholinergic drugs.
    Rush DK; Streit K
    Psychopharmacology (Berl); 1992; 106(3):375-82. PubMed ID: 1570386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Memantine ameliorates scopolamine-induced amnesia in chicks trained on taste-avoidance learning.
    Barber TA; Haggarty MK
    Neurobiol Learn Mem; 2010 May; 93(4):540-5. PubMed ID: 20170739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen levels modify scopolamine-induced amnesia in gonadally intact rats.
    de Macêdo Medeiros A; Izídio GS; Sousa DS; Macedo PT; Silva AF; Shiramizu VK; Cabral A; Ribeiro AM; Silva RH
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():99-108. PubMed ID: 24657885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacological studies on sufoxazine (Y-8894). (I) Effects on experimental amnesia in mice].
    Anami K; Yamamoto Y; Setoguchi M
    Nihon Yakurigaku Zasshi; 1985 Feb; 85(2):71-7. PubMed ID: 2859238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of dopamine D1 receptors in the medial septum improves scopolamine-induced amnesia in the dorsal hippocampus.
    Zarrindast MR; Ardjmand A; Ahmadi S; Rezayof A
    Behav Brain Res; 2012 Apr; 229(1):68-73. PubMed ID: 22226623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nociceptin/orphanin FQ and nocistatin on learning and memory impairment induced by scopolamine in mice.
    Hiramatsu M; Inoue K
    Br J Pharmacol; 1999 Jun; 127(3):655-60. PubMed ID: 10401555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (IV): Effects on experimental memory impairment in mice and rats.
    Yamamura M; Kinoshita K; Nakagawa H; Ishida R
    Jpn J Pharmacol; 1991 Feb; 55(2):241-53. PubMed ID: 1906119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The absence of effect of glucose on memory is associated with low susceptibility to the amnestic effects of scopolamine in a strain of mice.
    Messier C
    Behav Brain Res; 1998 Nov; 96(1-2):47-57. PubMed ID: 9821542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of pregabalin on fear-based conditioned avoidance learning and spatial learning in a mouse model of scopolamine-induced amnesia.
    Sałat K; Podkowa A; Malikowska N; Trajer J
    Toxicol Mech Methods; 2017 Mar; 27(3):181-190. PubMed ID: 27996351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serial position effect and selective amnesia induced by scopolamine in mice.
    Watanabe S; Yanagisawa N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 Feb; 20(1):17-20. PubMed ID: 10890019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal of scopolamine-induced amnesia of passive avoidance by pre- and post-training naloxone.
    Rush DK
    Psychopharmacology (Berl); 1986; 89(3):296-300. PubMed ID: 3088653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory avoidance memory deficit induced by scopolamine: Interaction of cholinergic and glutamatergic systems in the ventral tegmental area.
    Mahmoodi G; Ahmadi S; Pourmotabbed A; Oryan S; Zarrindast MR
    Neurobiol Learn Mem; 2010 Jul; 94(1):83-90. PubMed ID: 20403448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen replacement attenuates effects of scopolamine and lorazepam on memory acquisition and retention.
    Gibbs RB; Burke AM; Johnson DA
    Horm Behav; 1998 Oct; 34(2):112-25. PubMed ID: 9799622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological characterization of the ameliorating effect on learning and memory impairment and antinociceptive effect of KT-95 in mice.
    Hiramatsu M; Mizuno N; Kanematsu K
    Behav Brain Res; 2006 Feb; 167(2):219-25. PubMed ID: 16223533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of sustained release formulation of thyrotropin-releasing hormone on learning impairments caused by scopolamine and AF64A in rodents.
    Miyamoto M; Hirai K; Takahashi H; Kato K; Nishiyama M; Okada H; Nagaoka A
    Eur J Pharmacol; 1993 Jul; 238(2-3):181-9. PubMed ID: 8405091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of tolerance to amnesic effects of chlordiazepoxide in relation to GABAergic and cholinergic neuronal systems.
    Ishihara S; Hiramatsu M; Kameyama T; Nabeshima T
    Eur J Pharmacol; 1993 Jan; 230(3):313-20. PubMed ID: 8382617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-amnesic effect of Ficus religiosa in scopolamine-induced anterograde and retrograde amnesia.
    Kaur H; Singh D; Singh B; Goel RK
    Pharm Biol; 2010 Feb; 48(2):234-40. PubMed ID: 20645848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.